NCT06333691View on ClinicalTrials.gov

Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin

NACompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

February 1, 2024

Study Completion Date

February 15, 2024

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

DRUG

Calcium Gluconate

to compare the effectiveness of calcium gluconate, cabergoline and diosmin in preventing ovarian hyperstimulation syndrome in high-risk patient undergoing ICSI procedure.

Trial Locations (1)

Unknown

Minia University, Faculty of Pharmacy, Minya

All Listed Sponsors

lead

Minia University

OTHER